Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
255 | 3 | IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY | 46035 |
4030 | 2 | PROT CRYSTALLOG PROGRAM//ADV MED TREATMENTS//MDX 1097 | 762 |
33495 | 1 | CATARACT MICE//ENVIRONM OCCUPAT MED PSYCHIAT EPIDEMIOL//FAS RECEPTOR LIGAND | 137 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CATARACT MICE | authKW | 230051 | 1% | 100% | 1 |
2 | ENVIRONM OCCUPAT MED PSYCHIAT EPIDEMIOL | address | 230051 | 1% | 100% | 1 |
3 | FAS RECEPTOR LIGAND | authKW | 230051 | 1% | 100% | 1 |
4 | HISTIOGENIC TUMOR | authKW | 230051 | 1% | 100% | 1 |
5 | RETINAL HYPERPLASIA | authKW | 230051 | 1% | 100% | 1 |
6 | SUBRETINAL RETICULUM CELL SARCOMA | authKW | 230051 | 1% | 100% | 1 |
7 | THYMUS INFILTRATION | authKW | 230051 | 1% | 100% | 1 |
8 | VIRAL SUPERANTIGENS | authKW | 230051 | 1% | 100% | 1 |
9 | ANTI B CELL ANTIBODY | authKW | 115025 | 1% | 50% | 1 |
10 | EPIDIDYMAL TUMOR | authKW | 115025 | 1% | 50% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 658 | 34% | 0% | 46 |
2 | Oncology | 571 | 34% | 0% | 47 |
3 | Pathology | 142 | 9% | 0% | 13 |
4 | Cell Biology | 51 | 12% | 0% | 16 |
5 | Hematology | 50 | 7% | 0% | 9 |
6 | Transplantation | 34 | 4% | 0% | 5 |
7 | Medicine, Research & Experimental | 29 | 7% | 0% | 9 |
8 | Surgery | 9 | 7% | 0% | 9 |
9 | Biology | 8 | 3% | 0% | 4 |
10 | Veterinary Sciences | 7 | 4% | 0% | 5 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ENVIRONM OCCUPAT MED PSYCHIAT EPIDEMIOL | 230051 | 1% | 100% | 1 |
2 | AUSTRALIAN CANC FDN GENET | 32863 | 1% | 14% | 1 |
3 | EXPTL ONCOL 1 | 23003 | 1% | 10% | 1 |
4 | QUEEN MARY HOSP COMPOUND | 19169 | 1% | 8% | 1 |
5 | JOHNSON COMPREHENS CANC | 5749 | 1% | 3% | 1 |
6 | MED GENOME | 1998 | 1% | 1% | 1 |
7 | PITTSBURGH CANC | 783 | 1% | 0% | 1 |
8 | K LAN CANC | 735 | 1% | 0% | 1 |
9 | AIDS PROGRAM | 550 | 1% | 0% | 1 |
10 | NEW JERSEY MED | 512 | 3% | 0% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CRC CRITICAL REVIEWS IN TOXICOLOGY | 7794 | 1% | 2% | 2 |
2 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 4133 | 7% | 0% | 9 |
3 | CELLULAR IMMUNOLOGY | 3540 | 8% | 0% | 11 |
4 | CANCER COMMUNICATIONS | 2253 | 1% | 1% | 1 |
5 | PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH | 1665 | 1% | 1% | 1 |
6 | SURVEY OF IMMUNOLOGIC RESEARCH | 1343 | 1% | 1% | 1 |
7 | LEUKEMIA RESEARCH | 934 | 4% | 0% | 5 |
8 | JOURNAL OF IMMUNOLOGY | 824 | 10% | 0% | 14 |
9 | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 685 | 2% | 0% | 3 |
10 | VOPROSY ONKOLOGII | 589 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |